INVESTIGATION OF MODIFIABLE RISK FACTORS IN PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME
Öz
Anahtar Kelimeler
Destekleyen Kurum
Kaynakça
- Referans1. Piva SR, Fitzgerald K, Irrgang JJ, et al. Reliability of measures of impairments associated with patellofemoral pain syndrome. BMC Musculoskelet Disord. 2006; 31; 7:33.
- Referans2. Boling M, Padua D, Marshall S, et al. Gender differences in the incidence and prevalence of patellofemoral pain syndrome. Scand J Med Sci Sports. 2010; 20: 725-30.
- Referans3. Akarcali İ, Turgay N, Erden Z, et al. Assessment of muscle strength and soft tissue tightness in patients with patellofemoral pain syndrome. Acta Orthop Traumatol Turc. 2000; 34: 23-7.
- Referans4. Crossley K, Bennell K, Green S, et al. Physical therapy for patellofemoral pain: a randomized, double-blinded, placebo-controlled trial. Am J Sports Med. 2002; 30: 857-65.
- Referans5. van Linschoten R, van Middelkoop M, Berger MY, et al. Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial. BMJ. 2009; 20: 339.
- Referans6. Callaghan MJ, Selfe J. Has the incidence or prevalence of patellofemoral pain in the general population in the United Kingdom been properly evaluated? Phys Ther Sport. 2007; 8: 37–43.
- Referans7. Witvrouw E, Lysens R, Bellemans J, et al. Intrinsic risk factors for the development of anterior knee pain in an athletic population. A two-year prospective study. Am J Sports Med. 2000; 28: 480-9.
- Referans8. Haim A, Yaniv M, Dekel S, et al. Patellofemoral pain syndrome: validity of clinical and radiological features. Clin Orthop Relat Res. 2006; 451: 223-8.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Araştırma Makalesi
Yazarlar
Barış Nacır
0000-0002-9163-2569
Türkiye
Burcu Duyur Çakıt
0000-0003-1219-2356
Türkiye
Aynur Karagöz
0000-0003-3257-575X
Türkiye
Yayımlanma Tarihi
30 Nisan 2022
Gönderilme Tarihi
5 Mayıs 2021
Kabul Tarihi
17 Mart 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 55 Sayı: 1